KIMBERLY OFOEGBU: Open Payments
NPI 1588913552 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,282 in 72 payments from 13 companies in 2025. Trend: 2023 $250 · 2024 $831 · 2025 $2,282
Food & beverage: $2,184Education: $98
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 14 | $541 |
| UCB, Inc. | 9 | $361 |
| Regeneron Healthcare Solutions, Inc. | 8 | $277 |
| GENZYME CORPORATION | 4 | $239 |
| PFIZER INC. | 7 | $214 |
| ABBVIE INC. | 15 | $204 |
| Galderma Laboratories, L.P. | 1 | $145 |
| Janssen Biotech, Inc. | 6 | $143 |
| Lilly USA, LLC | 2 | $48 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $41 |
Products named: DUPIXENT, Bimzelx, ADBRY, ANZUPGO, NEMLUVIO, LITFULO, TREMFYA, SKYRIZI.
Industry payments across CT — which companies pay providers there.
